• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Jeff Chodakewitz - Articles and news items

Merck logo

Merck presents new Pharmacokinetic data on ISENTRESS® (raltegravir) at 14th European AIDS conference

Industry news / 16 October 2013 / Merck

Company confirms development program for investigational once daily (QD) dosing regimen of ISENTRESS…

Merck logo

Merck provides update on cardiovascular development program

Industry news, News / 26 August 2012 / Merck

Merck provided an update on the development programs for vorapaxar, extended release niacin/laropirprant and anacetrapib…